Tuesday, 2 Jun 2020

Stock Alert: Agilent Technologies Rises On Quarterly Results

Disney Springs Reopens On Wednesday

Walt Disney will partially reopen its Disney Springs at Walt Disney World Resort in Florida on May 20. It will implement number of new safety measures for the phased reopening.

Disney Springs is an outdoor shopping, dining, and entertainment complex at the Walt Disney World Resort in Lake Buena Vista, Florida, near Orlando.

“While our theme parks and resort hotels remain temporarily closed, the phased reopening of Disney Springs is a welcome milestone as we navigate through this unprecedented time together as responsibly as we can,” Disney Springs Vice President Matt Simon said in a statement.

The company said next week, many of its third-party operating participants will open at Disney Springs. On May 27, three stores and venues owned and operated by Disney – World of Disney, D-Luxe Burger and the Marketplace Co-Op – will reopen.

The company said that it will implement new health & safety measures and operational changes such as cashless payment options, a requirement to wear appropriate face covering, temperature screenings, social distancing measures, increased cleaning and disinfection procedures.

Stock Alert: Agilent Technologies Rises On Quarterly Results

Shares of Agilent Technologies, Inc. (A) are climbing more than 6% Friday on upbeat second-quarter results.

The company provides analytical instruments, software, services, and consumables for the entire laboratory workflow.

The company’s second-quarter adjusted earnings of $0.71 per share beat the consensus estimate polled by Thomson Reuters at $0.61 per share.

Revenue was $1.24 billion, flat compared with last year, and beat the estimates of $1.21 billion.

The company is supporting several aspects of COVID-19 research and testing along with therapeutic and vaccine development.

The company’s China business has recovered faster than expected and it expects the China growth recovery to continue throughout the year, as lab operations and investment continue to resume.

“Agilent is supporting several aspects of COVID-19 research and testing along with therapeutic and vaccine development. In Q2, this resulted in a one-point tailwind of growth, primarily in providing the instrumentation. There is potential that this will become a more meaningful tailwind in future quarters,” commented Mike McMullen, President, and Chief Executive Officer while talking to analysts during the conference call.

Agilent stock is currently trading at $85.95 and has traded in the range of $61.13- $90.64 in the last 52-weeks.

Stock Alert: Deckers Outdoor Spikes On Upbeat Results

Shares of Deckers Outdoor Corporation (DECK), that designs, markets, and distributes innovative footwear, apparel, and accessories, are climbing more than 7% after its fourth-quarter results surpassed estimates.

Earnings of $0.57 per share beat the average estimate of analysts polled by Thomson Reuters at $0.21 per share.

Net sales for the quarter, however, decreased 4.9% year-over-year to $374.9 million but beat the estimates of $374.19 million.

“Fiscal year 2020 performance was driven by the strength of our brand portfolio, fueled by targeted investments in our key initiatives, coupled with disciplined financial management,” said Dave Powers, President, and Chief Executive Officer. “We expect fiscal year 2021 results to be impacted depending on the duration and severity of the COVID-19 pandemic, but our in-demand brands, omnichannel capabilities, and healthy balance sheet position us well to weather this challenging environment.”

Deckers stock more than doubled from its 52-week low of $78.70, hit in March, currently trading at $182.01. The stock has recorded a 52-week high of $203.19 in February this year.

Stock Alert: Deckers Outdoor Spikes On Upbeat Results

Shares of Deckers Outdoor Corporation (DECK), that designs, markets, and distributes innovative footwear, apparel, and accessories, are climbing more than 7% after its fourth-quarter results surpassed estimates.

Earnings of $0.57 per share beat the average estimate of analysts polled by Thomson Reuters at $0.21 per share.

Net sales for the quarter, however, decreased 4.9% year-over-year to $374.9 million but beat the estimates of $374.19 million.

“Fiscal year 2020 performance was driven by the strength of our brand portfolio, fueled by targeted investments in our key initiatives, coupled with disciplined financial management,” said Dave Powers, President, and Chief Executive Officer. “We expect fiscal year 2021 results to be impacted depending on the duration and severity of the COVID-19 pandemic, but our in-demand brands, omnichannel capabilities, and healthy balance sheet position us well to weather this challenging environment.”

Deckers stock more than doubled from its 52-week low of $78.70, hit in March, currently trading at $182.01. The stock has recorded a 52-week high of $203.19 in February this year.

CORRECTED-BRIEF-Hyatt Files For Shelf Of Up To 13.3 Mln Shares By Selling Stockholders

(Corrects headline and bullet to say Hyatt files a shelf registration, not an offering by company)

May 21 (Reuters) – Hyatt Hotels Corp:

* HYATT HOTELS CORP FILES FOR SHELF OF UP TO 13.3 MILLION SHARES OF CLASS A COMMON STOCK, BY SELLING STOCKHOLDERS – SEC FILING

Lawn care, BBQ companies among those seeing big business as Winnipeggers stay home

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Stock Alert: Agilent Technologies Rises On Quarterly Results

Shares of Agilent Technologies, Inc. (A) are climbing more than 6% Friday on upbeat second-quarter results.

The company provides analytical instruments, software, services, and consumables for the entire laboratory workflow.

The company’s second-quarter adjusted earnings of $0.71 per share beat the consensus estimate polled by Thomson Reuters at $0.61 per share.

Revenue was $1.24 billion, flat compared with last year, and beat the estimates of $1.21 billion.

The company is supporting several aspects of COVID-19 research and testing along with therapeutic and vaccine development.

The company’s China business has recovered faster than expected and it expects the China growth recovery to continue throughout the year, as lab operations and investment continue to resume.

“Agilent is supporting several aspects of COVID-19 research and testing along with therapeutic and vaccine development. In Q2, this resulted in a one-point tailwind of growth, primarily in providing the instrumentation. There is potential that this will become a more meaningful tailwind in future quarters,” commented Mike McMullen, President, and Chief Executive Officer while talking to analysts during the conference call.

Agilent stock is currently trading at $85.95 and has traded in the range of $61.13- $90.64 in the last 52-weeks.

Related Posts